Your browser doesn't support javascript.
loading
Favourable effect of a 'second hit' after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial.
Hartman, Linda; Rasch, Linda A; Turk, Samina A; Ter Wee, Marieke M; Kerstens, Pit J S M; van der Laken, Conny J; Nurmohamed, Michael T; van Schaardenburg, Dirkjan; van Tuyl, Lilian H D; Voskuyl, Alexandre E; Boers, Maarten; Lems, Willem F.
Affiliation
  • Hartman L; Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
  • Rasch LA; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
  • Turk SA; Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
  • Ter Wee MM; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, The Netherlands.
  • Kerstens PJSM; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
  • van der Laken CJ; Department of Rheumatology, Dijklander Ziekenhuis, Hoorn, The Netherlands.
  • Nurmohamed MT; Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
  • van Schaardenburg D; Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
  • van Tuyl LHD; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, The Netherlands.
  • Voskuyl AE; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, The Netherlands.
  • Boers M; Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Universiteit van Amsterdam, Amsterdam, The Netherlands.
  • Lems WF; Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
Rheumatology (Oxford) ; 62(6): 2098-2105, 2023 06 01.
Article in En | MEDLINE | ID: mdl-36205538
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2023 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2023 Type: Article Affiliation country: Netherlands